Seres Health pulls in $10 mln Series B
Seres Health said Monday that it has received $10 million in Series B funding. The investors included Flagship Ventures, Enso Ventures, Mayo Clinic and Alexandria Venture Investments. Based in Cambridge, Mass., Seres Health is a clinical stage biotherapeutic company focused on developing drugs that target the human microbiome.
9 June 2014•2 mins read
